Spotlight on Veeva: 10 Questions with Kimberly Paris, Global Vice President of Quality Assurance
6 / 64 articles displayed
Awards
Quotient Sciences announced that it has received a Transatlantic Growth Award at a ceremony hosted by BritishAmerican Business in London. The award, in the 'UK SME in the US' category, was presented to Gordon Cameron, CFO, Quotient Sciences.
News
Quotient Sciences, and Druggability Technologies (DRGT), a specialty pharmaceutical company, announced a collaboration today to utilize Quotient’s integrated Translational Pharmaceutics® platform to advance the development of DRGT-46, a novel, fast-acting formulation of celecoxib using proprietary super-API compositions developed by DRGT. This will be Quotient’s first Translational Pharmaceutics program delivered from its U.S. operating facilities.
News
Quotient Sciences, has invested in additional spray drying capabilities at its formulation development and clinical trial manufacturing facility in Garnet Valley, PA.
News
The HRA and MHRA have been exploring opportunities to improve the service being offered for the approval and ongoing management of Clinical Trials of Medicinal Products (CTIMPs) and launched a pilot to test an integrated process – the Combined Ways of Working Pilot.
News
Quotient Sciences, a leading drug development services organization, has significantly expanded its formulation development and clinical trial manufacturing operations at its Reading, U.K., facility. The program’s investment has tripled the site’s GMP capacity, added new equipment for solid oral dose manufacturing and significantly increased staffing levels.
Growth
Quotient Sciences, announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, Pa. The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial manufacturing.
Ask us a question
